The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in Escherichia coli
Open accessAbstract
Bacterial populations produce a small number of persister cells that exhibit multidrug tolerance. Persister cells are largely responsible for the antibiotic recalcitrance of biofilm infections. The mechanism of persister cell formation largely remains unknown due to the challenges in identifying persister genes. We screened an ordered comprehensive library of 3,985 Escherichia coli knockout strains to identify mutants with altered antibiotic tolerance. Stationary-state cultures in 96-well plates were exposed to ofloxacin at a concentration which allows only tolerant persister cells to survive. The persister cell level of each culture was determined. A total of 150 mutants with decreased persistence were identified in the initial screen, and subsequent validation confirmed that neither the growth rate nor the ofloxacin MIC was affected for 10 of them. The genes affected in these strains were dnaJ and dnaK (chaperones), apaH (diadenosine tetraphosphatase), surA (peptidyl-prolyl cis - trans isomerase), fis and hns (global regulators), hnr (response regulator of RpoS), dksA (transcriptional regulator of rRNA transcription), ygfA (5-formyl-tetrahydrofolate cyclo-ligase), and yigB (flavin mononucleotide [FMN] phosphatase). The prominent presence of global regulators among these strains pointed to the likely redundancy of persister cell formation mechanisms: the elimination of a regulator controlling several redundant persister genes would be expected to produce a phenotype. This observation is consistent with previous findings for a possible role of redundant genes such as toxin/antitoxin modules in persister cell formation. ygfA and yigB were of special interest. The mammalian homolog of YgfA (methenyltetrahydrofolate synthetase) catalyzes the conversion of 5-formyl-tetrahydrofolate (THF) into the rapidly degraded 5,10-methenyl-THF, depleting the folate pool. The YigB protein is a phosphatase of FMN which would deplete the pool of this cofactor. Stochastic overexpression of these genes could lead to dormancy and, hence, tolerance by depleting the folate and FMN pools, respectively. Consistent with this scenario, the overexpression of both genes produced increased tolerance to ofloxacin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Determination of minimum inhibitory concentrations
Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.5 · Cited by 4,129
Culture Medium for Enterobacteria
Neidhardt, F. C., Bloch, P. L., & Smith, D. F. (1974) · Journal of Bacteriology · doi:10.1128/jb.119.3.736-747.1974 · Cited by 2,958
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 1×
“Recent progress in this area can be summarized as follows: persisters are nongrowing (6), dormant (50) cells; persistence is not heritable (27); persisters probably form a single subpopulation tolerant to unrelated antibiotics (65); a transcriptome of isolated persisters points to toxin/ antitoxin modules as possible…”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 3×
“Persister cells are dormant, multidrug-tolerant cells and play a major role in biofilm recalcitrance to antimicrobials (12, 27, 53, 50, 33).”
BackgroundSelf-citationLung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Kitagawa, M., Ara, T., Arifuzzaman, M., Ioka-Nakamichi, T., Inamoto, E., Toyonaga, H., & Mori, H. (2006) · DNA Research · doi:10.1093/dnares/dsi012 · Cited by 1,388
Cited by
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Self-citationDistinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Self-citationPersistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025
“In E. coli , non-persister stationary phase cells were killed by treatment with 5 μg/mL ofloxacin for 4 hours 25, 26 .”
Mechanisms of bacterial persistence during stress and antibiotic exposure
Harms, A., Maisonneuve, E., & Gerdes, K. (2016) · Science · doi:10.1126/science.aaf4268 · Cited by 919
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
Dörr, T., Vulić, M., & Lewis, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000317 · Cited by 782
Self-citationActivated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J. N., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 672
Self-citationMolecular Mechanisms Underlying Bacterial Persisters
Maisonneuve, E., & Gerdes, K. (2014) · Cell · doi:10.1016/j.cell.2014.02.050 · Cited by 645
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Self-citationATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508
Self-citationMicrobial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 460
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
“aeruginosa, these include dksA, relA and spoT, genes associated with the stringent response (Hansen et al., 2008; Korch et al., 2003; Viducic et al., 2006).”
BackgroundThe unexhausted potential of E. coli
Blount, Z. D. (2015) · eLife · doi:10.7554/elife.05826 · Cited by 424
Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters
Keren, I., Minami, S., Rubin, E., & Lewis, K. (2011) · mBio · doi:10.1128/mbio.00100-11 · Cited by 404
Self-citationPu, Y., Li, Y., Jin, X., Tian, T., Ma, Q., Zhao, Z., Lin, S.-Y., Chen, Z., Li, B., Yao, G., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.022 · Cited by 390
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells
Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M. A. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.035 · Cited by 381
Formation, physiology, ecology, evolution and clinical importance of bacterial persisters
Van den Bergh, B., Fauvart, M., & Michiels, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux001 · Cited by 381
Metabolic Control of Persister Formation in Escherichia coli
Amato, S. M., Orman, M. A., & Brynildsen, M. P. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.04.002 · Cited by 370
A global view of antibiotic resistance
Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martínez-Solano, L., & Sánchez, M. B. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00142.x · Cited by 356
Toxin–antitoxin systems: why so many, what for?
Van Melderen, L. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.10.006 · Cited by 321
Bacterial persisters: molecular mechanisms and therapeutic development
Niu, H., Gu, J., & Zhang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01866-5 · Cited by 310
Metabolic regulation of antibiotic resistance
Martínez, J. L., & Rojo, F. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00282.x · Cited by 304
Bacterial Persisters and Infection: Past, Present, and Progressing
Gollan, B., Grabe, G., Michaux, C., & Helaine, S. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115650 · Cited by 280
HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase
Kaspy, I., Rotem, E., Weiss, N., Ronin, I., Balaban, N. Q., & Glaser, G. (2013) · Nature Communications · doi:10.1038/ncomms4001 · Cited by 268
Bernier, S. P., Lebeaux, D., DeFrancesco, A. S., Valomon, A., Soubigou, G., Coppée, J.-Y., Ghigo, J.-M., & Beloin, C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003144 · Cited by 262
The role of metabolism in bacterial persistence
Amato, S. M., Fazen, C. H., Henry, T. C., Mok, W. W. K., Orman, M. A., Sandvik, E. L., Volzing, K. G., & Brynildsen, M. P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00070 · Cited by 258
Patients with Long-Term Oral Carriage Harbor High-Persister Mutants of Candida albicans
LaFleur, M. D., Qi, Q., & Lewis, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-09 · Cited by 237
Self-citationPersister Cells: Molecular Mechanisms Related to Antibiotic Tolerance
Lewis, K. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-28951-4_8 · Cited by 217
Self-citationPhenotypic Resistance to Antibiotics
Corona, F., & Martinez, J. (2013) · Antibiotics · doi:10.3390/antibiotics2020237 · Cited by 205
Chaperone networking facilitates protein targeting to the bacterial cytoplasmic membrane.
Castanié-Cornet, M.-P., Bruel, N., & Genevaux, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.11.007 · Cited by 129
Metadata
- Authors
- Hansen, S., Lewis, K., & Vulić, M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-08
- Volume
- 52
- Issue
- 8
- Pages
- 2718-2726
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2168606178
- Cited by
- 300
- References
- 59
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.